TerrAscend (TSNDF) Stock Price, News & Analysis

Company Overview

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: $0.49 to $0.56
• 50-Day Range: $0.24 to $0.55
• 52-Week Range: $0.23 to $1.75
• Volume: 855,846 shs
• Average Volume: 571,288 shs
• Market Capitalization: $169.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

TerrAscend Stock Analysis - MarketRank™

TerrAscend scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for TerrAscend.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for TerrAscend are expected to grow in the coming year, from ($0.14) to ($0.04) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of TerrAscend is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of TerrAscend is -1.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

TerrAscend has a P/B Ratio of 0.92. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.58% of the outstanding shares of TerrAscend have been sold short.

Short Interest Ratio / Days to Cover

TerrAscend has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in TerrAscend has recently decreased by 22.22%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

TerrAscend does not currently pay a dividend.

Dividend Growth

TerrAscend does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.58% of the outstanding shares of TerrAscend have been sold short.

Short Interest Ratio / Days to Cover

TerrAscend has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in TerrAscend has recently decreased by 22.22%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: -0.15

News Sentiment

TerrAscend has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for TerrAscend this week, compared to 1 article on an average week.

MarketBeat Follows

2 people have added TerrAscend to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, TerrAscend insiders have not sold or bought any company stock.

Percentage Held by Insiders

32.16% of the stock of TerrAscend is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.83% of the stock of TerrAscend is held by institutions.

TSNDF Stock Analysis - Frequently Asked Questions

How have TSNDF shares performed this year?

TerrAscend's stock was trading at $0.65 on January 1st, 2025. Since then, TSNDF shares have decreased by 14.7% and is now trading at $0.5547.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TSNDF) released its quarterly earnings results on Thursday, August, 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The business earned $65.01 million during the quarter, compared to analysts' expectations of $64.87 million. TerrAscend had a negative net margin of 40.86% and a negative trailing twelve-month return on equity of 21.15%.

How do I buy shares of TerrAscend?

Shares of TSNDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/07/2025
• Today: 8/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:TSNDF
• Previous Symbol: OTC:TSNDF
• CIK: 1778129
• Web: www.terrascend.com
• Phone: 855-837-7295
• Fax: N/A
• Employees: 1,163
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$80.23 million
• Net Margins: -40.86%
• Pretax Margin: -16.12%
• Return on Equity: -21.15%
• Return on Assets: -6.23%

Debt

• Debt-to-Equity Ratio: 1.42
• Current Ratio: 1.31
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $306.68 million
• Price / Sales: 0.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.60 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 306,120,000
• Free Float: 207,670,000
• Market Cap: $169.80 million
• Optionable: Not Optionable
• Beta: 1.39